Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver

Journal of Virology

Volumn 73, Issue 7, 1999, Pages 5438-5447

  Nakai, Hiroyuki ^a,b,c   Iwaki, Yuichi ^b   Kay, Mark A ^c   Couto, Linda B ^a  

^a Avigen Inc   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; CELL DNA; COLLAGEN TYPE 1; RIBOSOME RNA; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL TISSUE; ARTICLE; CELL JUNCTION; DNA DETERMINATION; DNA FLANKING REGION; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENOME; LIVER; MOUSE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; VIRUS EXPRESSION; VIRUS RECOMBINANT;

EID: 0032990410     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.7.5438-5447.1999     Document Type: Article

References (39)

1. Allen, J. M., D. J. Debelak, T. C. Reynolds, and D. Miller. 1997. Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production. J. Virol. 71:6815-6822.
2. Balagué, C., M. Kalla, and W.-W. Zhang. 1997. Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J. Virol. 71:3299-3306.
3. Cheung, A. K. M., M. D. Hoggan, W. W. Hauswirth, and K. I. Berns. 1980. Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J. Virol. 33:739-748.
4. Clark, K. R., T. J. Sferra, and P. R. Johnson. 1997. Recombinant adeno-associated virus vectors mediate long-term transgene expression in muscle. Hum. Gene Ther. 8:659-669.
5. Craigie, R. 1992. Hotspots and warmspots: integration specificity of retro-elements. Trends Genet. 8:187-190.
6. Duan, D., P. Sharma, J. Yang, Y. Yue, L. Dudus, Y. Zhang, K. J. Fisher, and J. F. Engelhardt. 1998. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virol. 72:8568-8577.
7. Dyall, J., and K. I. Berns. 1998. Site-specific integration of adeno-associated virus into an episome with the target locus via a deletion-substitution mechanism. J. Virol. 72:6195-6198.
8. Fisher, K. J., K. Jooss, J. Alston, Y. Yang, S. E. Haecker, K. High, R. Pathak, S. E. Raper, and J. M. Wilson. 1997. Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3:306-312.
9. Giraud, C., E. Winocour, and K. I. Berns. 1995. Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J. Virol. 69:6917-6924.
10. Herzog, R. W., J. N. Hagstrom, S.-H. Rung, S. H. Tai, J. M. Wilson, K. J. Fisher, and K. A. High. 1997. Stable gene transfer and expresson of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA 94:5804-5809.
11. Kaplitt, M. G., P. Leone, R. J. Samulski, X. Xiao, D. W. Pfaff, K. L. O'Malley, and M. J. During. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:148-154.
12. Kessler, P. D., G. M. Podsakoff, X. Chen, S. A. McQuiston, P. C. Colosi, L. A. Matelis, G. J. Kurtzman, and B. J. Byrne. 1996. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93:14082-14087.
13. Koebert, D. D., I. E. Alexander, C. L. Halbert, D. W. Russell, and A. D. Miller. 1997. Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 94:1429-1431.
14. Kotin, R. M., M. Siniscalco, R. J. Samulski, X. D. Zhu, L. Hunter, C. A. Laughlin, S. McLaughlin, N. Muzyczka, M. Rocchi, and K. I. Berns. 1990. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 87:2211-2215.
15. Kotin, R. M. 1994. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum. Gene Ther. 5:793-801.
16. Linden, R. M., E. Winocour, and K. I. Berns. 1996. The recombination signals for adeno-associated virus site-specific integration. Proc. Natl. Acad. Sci. USA 93:7966-7972.
17. Matsushita, T., S. Elliger, C. Elliger, G. Podsakoff, L. Villarreal, G. J. Kurtzman, Y. Iwaki, and P. Colosi. 1998. Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther. 5:938-945.
18. McCarty, D. M., J. H. Ryan, S. Zolotukhin, X. Zhou, and N. Muzyczka. 1994. Interaction of the adeno-associated virus Rep protein with a sequence within the A palindrome of the viral terminal repeat. J. Virol. 68:4998-5006.
19. Mclaughlin, S. K., P. Collis, P. L. Hermonat, and N. Muzyczka. 1988. Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 62:1963-1973.
20. Miao, C. H., R. O. Snyder, D. B. Schowalter, G. A. Patijn, B. Donahue, B. Winther, and M. A. Kay. 1998. The kinetics of rAAV integration in the liver. Nat. Genet. 19:13-15.
21. Nakai, H., R. W. Herzog, J. N. Hagstrom, J. Walter, S.-H. Kung, E. Y. Yang, S. Y. Tai, Y. Iwaki, G. J. Kurtzman, K. J. Fisher, P. Colosi, L. B. Couto, and K. A. High. 1998. Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood 91:4600-4607.
22. Nakai, H., et al. Unpublished data.
23. Ponnazhagan, S., D. Erikson, W. G. Kearns, S. Z. Zhou, P. Nahreini, X.-S. Wang, and A. Srivastava. 1997. Lack of site-specific integration of the recombinant adeno-associated virus 2 genome in human cells. Hum. Gene Ther. 8:275-284.
24. Rehn, M., E. Hintikka, and T. Pihlajaniemi. 1996. Characterization of the mouse gene for the α 1 chain of type XVIII collagen (Coll8a1) reveals that the three variant N-teminal polypeptide forms are transcribed from two widely separated promoters. Genomics 32:436-446.
25. Rivadeneira, E. D., N. C. Popescu, D. B. Zimonjic, G. S. Cheng, P. J. Nelson, M. D. Ross, J. A. DiPaolo, and M. E. Klotman. 1998. Sites of recombinant adeno-associated virus integration. Int. J. Oncol. 12:805-810.
26. Rutledge, E. A., and D. W. Russell. 1997. Adeno-associated virus vector integration junctions. J. Virol. 71:8429-8436.
27. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
28. Samulski, R. J., A. Srivastava, K. I. Berns, and N. Muzyczka. 1983. Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell 33:135-143.
29. Samulski, R. J., X. Zhu, X. Xiao, J. D. Brook, D. E. Housman, N. Epstein, and L. A. Hunter. 1991. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10:3941-3950.
30. Shin, C.-C., J. P. Stoye, and J. M. Coffin. 1988. Highly preferred targets for retrovirus integration. Cell 53:531-537.
31. Snyder, R. O., S. K. Spratt, C. Lagarde, D. Bohl, B. Kasper, B. Sloan, L. K. Cohen, and O. Danos. 1997. Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum. Gene Ther. 8:1898-1900.
32. Snyder, R. O., C. H. Miao, G. A. Patijn, S. K. Spratt, O. Danos, D. Nagy, A. M. Gown, B. Winther, L. Meuse, L. K. Cohen, A. R. Thompson, and M. A. Kay. 1997. Persistent and therapeutic concentration of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16:270-276.
33. Walter, J., Q. You, N. Hagstrom, M. Sands, and K. A. High. 1996. Successful expresson of human factor IX following repeat administration of an adeno-viral vector in mice. Proc. Natl. Acad. Sci. USA 93:3056-3061.
34. Weitzman, M. D., S. R. M. Kyöstiö, R. M. Kotin, and R. A. Owen. 1994. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci. USA 91:5808-5812.
35. Wolff, J. A., J. J. Ludtke, G. Ascadi, P. Williams, and A. Jani. 1992. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1:363-369.
36. Wu, P., M. I. Phillips, J. Bui, and E. F. Terwilliger. 1998. Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing cell targets. J. Virol. 72:5919-5926.
37. Xiao, W., S. C. Berta, M. M. Lu, A. D. Moscioni, J. Tazelaar, and J. M. Wilson. 1998. Adeno-associated virus as a vector for liver-directed gene therapy. J. Virol. 72:10222-10226.
38. Xiao, X., and R. J. Samulski. 1996. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:8098-8108.
39. Yang, C. C., X. Xiao, X. Zhu, D. C. Ansardi, N. D. Epstrein, M. R. Frey, A. G. Matera, and R. J. Samulski. 1997. Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. J. Virol. 71:9231-9246.